CAG Precision Diagnostics In Cardiology are launching Denmark’s largest genetic study of blood samples from around 120,000 cardiovascular patients. The study can be used to customise patient treatment, improve diagnostic evaluation and treatment of cardiovascular diseases as well as limit unnecessary preventive treatment.
The study is the first and largest of its kind in Denmark, and can become a decisive step towards offering more personal treatment to patients with the most common cardiovascular diseases.
The researchers will focus on markers that can be linked to the five most common cardiovascular diseases: high blood pressure, atherosclerosis/hardening of the arteries, cholesterol diseases, arrhythmia and heart failure.
The mortality rate of cardiovascular patients has dropped significantly over the past two decades, but cardiovascular diseases are still the cause of around one in four of all deaths in Denmark.
The new research project is the first major joint activity in Copenhagen Health Science Partners – the cross-disciplinary research collaboration between the University of Copenhagen and the Capital Region of Denmark.
Henning Bundgaard, Professor of Cardiology at The Capital Region’s Unit of Inherited Cardiac Diseases, Faculty of Health and Medical Sciences, University of Copenhagen, Rigshospitalet.
Telephone: +45 26 11 22 90
Søren Brunak, professor at Novo Nordisk Foundation Center for Protein Research Faculty of Health and Medical Sciences, University of Copenhagen
Telephone: +45 35 32 50 26